AI Protects the First Life: BioticsAI Receives FDA Approval to Accurately Address Fetal Misdiagnosis Challenges
The AI software of medical technology company BioticsAI has received FDA approval, used to assist doctors in detecting fetal abnormalities through ultrasound images, improving the accuracy of prenatal screening. The company's founder was inspired by his family's background in obstetrics and gynecology, dedicated to integrating AI technology into the healthcare field.